Continuous noninvasive ventilatory support outcomes for patients with neuromuscular disease: a multicenter data collaboration
Authors:
- M.R. GonçalvesMGM.R. Gonçalves
- J.R. BachJBJ.R. Bach
- Y. IshikawaY. Ishikawa
- J.C. WinckJWJ.C. Winck
- the International Study Group on Continuous Noninvasive Ventilatory Support in Neuromuscular Disease (CNVSND)T(the International Study Group on Continuous Noninvasive Ventilatory Support in Neuromuscular Disease (CNVSND)
Open Access
- 14 October 2021
- journal article
- research article
- Published by Taylor & Francis in Pulmonology
- Vol. 27 (6) , 509-517
Abstract
Background: Typically, patients with progressive neuromuscular disorders (NMDs) develop acute respiratory failure (ARF), are intubated, and when failing spontaneous breathing trials (SBTs) undergo a tracheotomy and receive tracheostomy mechanical ventilation (TMV). However, increasing numbers of patients use nasal noninvasive ventilation (NIV), initially for sleep and this is extended to continuous dependence (CNVS). This can be used as a strategy to assist in successful extubation . We retrospectively reviewed 19 centers offering CNVS and mechanical insufflation-exsufflation (MI-E) as an alternative to TMV. Methods: Centers with publications or presentations concerning CNVS outcomes data were pooled for amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD), and spinal muscular atrophy type 1 (SMA1). Progression to CNVS dependence without hospitalization, duration of dependence, and extubations and decannulations to CNVS were recorded. Prolongation of life was defined by duration of CNVS dependence without ventilator free breathing ability (VFBA). Results: There were 1623 part time (<23 h/day) NVS users with ALS, DMD, and SMA1 from 19 centers in 16 countries of whom 761 (47%) were CNVS dependent for 2218 patient-years. This included: 335 ALS patients for a mean 1.2 ± 1.0 (range to 8) years each; 385 DMD patients for 5.4 ± 1.6 (range to 29) years; and 41 SMA1 patients for 5.9 ± 1.8 (range to 20) years. Thirty-five DMD and ALS TMV users were decannulated to CNVS and MI-E. At data collection 494 (65%) patients were CNVS dependent but 110 (74 of whom with bulbar ALS), had undergone tracheotomies. Conclusions: ALS, DMD, and SMA1 patients can become CNVS dependent without requiring hospitalization but CNVS cannot be used indefinitely for many patients with advanced upper motor neuron diseases.Keywords
This publication has 56 references indexed in Scilit:
- British Thoracic Society guideline for respiratory management of children with neuromuscular weaknessThorax, 2012
- Outcome of goal-directed non-invasive ventilation and mechanical insufflation/exsufflation in spinal muscular atrophy type IArchives of Disease in Childhood, 2010
- At Home and on Demand Mechanical Cough Assistance Program for Patients With Amyotrophic Lateral SclerosisAmerican Journal of Physical Medicine & Rehabilitation, 2010
- Chronic respiratory care for neuromuscular diseases in adultsEuropean Respiratory Journal, 2009
- Tracheostomy tubes are not needed for Duchenne muscular dystrophyEuropean Respiratory Journal, 2007
- Mechanical Insufflation–Exsufflation Improves Outcomes for Neuromuscular Disease Patients with Respiratory Tract InfectionsAmerican Journal of Physical Medicine & Rehabilitation, 2005
- Ventilator Weaning by Lung Expansion and DecannulationAmerican Journal of Physical Medicine & Rehabilitation, 2004
- Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairmentAmyotrophic Lateral Sclerosis, 2002
- Prevention of Pulmonary Morbidity in Patients With Neuromuscular DisordersChest, 1998
- ETHICAL CONSIDERATIONS IN THE MANAGEMENT OF INDIVIDUALS WITH SEVERE NEUROMUSCULAR DISORDERSAmerican Journal of Physical Medicine & Rehabilitation, 1994